Cargando…
Cessation of Neoangiogenesis in Alzheimer's Disease Follows Amyloid-beta Immunization
Pathogenic neoangiogenesis in Alzheimer's disease (AD) is due to amyloid-beta (Aβ) and results in blood-brain barrier (BBB) leakiness in AD. It likely occurs as a compensatory response to impaired cerebral blood flow and provides a strong link between brain vascularity and AD. Aβ immunotherapy...
Autores principales: | Biron, Kaan E., Dickstein, Dara L., Gopaul, Rayshad, Fenninger, Franz, Jefferies, Wilfred A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584312/ https://www.ncbi.nlm.nih.gov/pubmed/23446889 http://dx.doi.org/10.1038/srep01354 |
Ejemplares similares
-
Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease
por: Biron, Kaan E., et al.
Publicado: (2011) -
Adjusting the compass: new insights into the role of angiogenesis in Alzheimer’s disease
por: Jefferies, Wilfred A, et al.
Publicado: (2013) -
Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics
por: Singh, Chaahat S.B., et al.
Publicado: (2021) -
Neoangiogenesis in prostate cancer
por: Łuczyńska, Elżbieta, et al.
Publicado: (2013) -
Major Histocompatibility Complex class I proteins are critical for maintaining neuronal structural complexity in the aging brain
por: Lazarczyk, Maciej J., et al.
Publicado: (2016)